Clinical Trial Update: Standard Versus High Dose Inactivated Influenza Vaccine in RA [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing standard-dose versus high-dose inactivated influenza vaccine in patients with rheumatoid arthritis; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Inactivated influenza vaccine (standard-dose vs high-dose) (inactivated influenza vaccine)

Snippet

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED | Results posted: 2024-08-13